Modern Diagnostic & Research Centre IPO
Modern Diagnostic & Research Centre IPO Details
-
उघडण्याची तारीख
31 डिसेंबर 2025
-
बंद तारीख
02 जानेवारी 2026
- IPO प्राईस रेंज
₹85 ते ₹90
- IPO साईझ
₹ 37 कोटी
Modern Diagnostic & Research Centre IPO Timeline
Modern Diagnostic & Research Centre IPO Subscription Status
| तारीख | क्यूआयबी | एनआयआय | रिटेल | एकूण |
|---|---|---|---|---|
| 31-Dec-2025 | 4.01 | 7.96 | 5.51 | 5.60 |
| 1-Jan-2026 | 8.94 | 53.22 | 33.85 | 30.87 |
अंतिम अपडेट: 02 जानेवारी 2026 6:18 PM 5paisa द्वारे
Modern Diagnostic & Research Centre (MDRC) is an Indian diagnostic services provider that began operations in 1985 in Gurugram and has grown into a leading pathology and imaging business. It offers a wide spectrum of diagnostic facilities, including high-end pathology and radiology tests, with in-house capability to perform over 2,500 tests across its network. MDRC operates multiple labs and touchpoints across India, serving over 1.5 crore customers with accredited, quality-focused diagnostic solutions. The company emphasises advanced technology, reliable results, and extensive experience in healthcare diagnostics.
येथे स्थापित: 1985
Managing Director: Dr. D.S Yadav
Modern Diagnostic & Research Centre Objectives
1. Funding capital expenditure for purchase of medical equipments for diagnostic centre and laboratories (₹20.69 कोटी)
2. Funding working capital requirement (₹8 Cr)
3. Repayment of certain outstanding borrowings availed by the company (₹1 Cr)
4. सामान्य कॉर्पोरेट खर्च
Modern Diagnostic & Research Centre IPO Size
| प्रकार | साईझ |
|---|---|
| एकूण IPO साईझ | ₹ 37 कोटी |
| विक्रीसाठी ऑफर | - |
| नवीन समस्या | ₹ 37 कोटी |
Modern Diagnostic & Research Centre IPO Lot Size
| ॲप्लिकेशन | लॉट्स | शेअर्स | रक्कम (₹) |
|---|---|---|---|
| रिटेल (किमान) | 2 | 3,200 | 2,72,000 |
| रिटेल (कमाल) | 2 | 3,200 | 2,88,000 |
| एस-एचएनआय (किमान) | 3 | 4,800 | 4,08,000 |
| S-HNI (कमाल) | 6 | 9,600 | 8,64,000 |
| बी-एचएनआय (किमान) | 8 | 11,200 | 10,08,000 |
Modern Diagnostic & Research Centre IPO Reservation
| इन्व्हेस्टर्स कॅटेगरी | सबस्क्रिप्शन (वेळा) | ऑफर केलेले शेअर्स* | यासाठी शेअर्स बिड | एकूण रक्कम (कोटी)* |
|---|---|---|---|---|
| क्यूआयबी (एक्स अँकर) | 8.94 | 7,82,400 | 69,98,400 | 62.99 |
| गैर-संस्थात्मक खरेदीदार | 53.22 | 5,85,600 | 3,11,63,200 | 280.47 |
| bNII (₹10 लाखांपेक्षा अधिक बोली) | 63.42 | 3,93,600 | 2,49,61,600 | 224.65 |
| sNII (₹10 लाखांपेक्षा कमी बोली) | 32.30 | 1,92,000 | 62,01,600 | 55.81 |
| वैयक्तिक गुंतवणूकदार (2 लॉट्ससाठी इंड कॅटेगरी बिडिंग) | 33.85 | 13,63,200 | 4,61,40,800 | 415.27 |
| एकूण** | 30.87 | 27,31,200 | 8,43,02,400 | 758.72 |
*"ऑफर केलेले शेअर्स" आणि "एकूण रक्कम" जारी किंमतीच्या श्रेणीच्या वरच्या मर्यादेचा वापर करून कॅल्क्युलेट केले जातात.
**अँकर इन्व्हेस्टरला (किंवा मार्केट मेकर्स) वाटप केलेले शेअर्स ऑफर केलेल्या एकूण शेअर्सच्या संख्येमधून वगळले जातात.
| तपशील (₹ कोटीमध्ये) | FY23 | FY24 | FY25 |
| महसूल | 56.28 | 67.13 | 77.95 |
| EBITDA | -1 | 11.05 | 17.96 |
| पॅट | -5.73 | 5.8 | 9 |
| तपशील (₹ कोटीमध्ये) | FY23 | FY24 | FY25 |
| एकूण मालमत्ता | 36.54 | 49.49 | 64.57 |
| शेअर कॅपिटल | 1 | 1 | 1 |
| एकूण दायित्व | 36.54 | 49.49 | 64.57 |
| कॅश फ्लो (₹ कोटी) | FY23 | FY24 | FY25 |
| ऑपरेटिंग उपक्रमांमधून/(वापरलेले) निव्वळ कॅश निर्माण | -0.12 | 7.93 | 13.73 |
| गुंतवणूक उपक्रमांमधून/(वापरलेले) निव्वळ कॅश निर्माण | 2.12 | -11.03 | -13.14 |
| फायनान्सिंग उपक्रमांमधून/(वापरलेले) निव्वळ कॅश निर्माण | -6.47 | 3.36 | -0.22 |
| कॅश आणि कॅश समतुल्यांमध्ये निव्वळ वाढ (कमी) | -4.48 | 0.26 | 0.37 |
सामर्थ्य
1. Established diagnostic service provider with decades of operational experience
2. Integrated pathology and radiology offerings across multiple centres
3. Ability to conduct a wide range of routine and specialised diagnostic tests in-house
4. Focus on quality systems, accreditations, and standardised operating processes
कमकुवतता
1. Revenue concentration linked to a limited geographic presence
2. High operating costs due to equipment, technology, and skilled manpower requirements
3. Dependence on timely sample collection, processing, and reporting infrastructure
4. Exposure to operational disruptions at laboratories or diagnostic centres
संधी
1. Rising demand for diagnostic and preventive healthcare services in India
2. Scope to expand centre network and test offerings in existing and new regions
3. Increasing preference for organised diagnostic service providers
4. Potential to deepen relationships with hospitals, doctors, and corporate clients
धोके
1. Intense competition from national diagnostic chains and regional laboratories
2. Regulatory and compliance risks related to healthcare and clinical standards
3. Pricing pressure due to competition and negotiated institutional contracts
4. Risks related to technological obsolescence and data security
1. Offers diagnostic services in both pathology and radiology, catering to diverse healthcare testing needs.
2. Proposed listing on the BSE SME platform, providing market access for growth capital.
3. Experienced promoters and structured corporate setup with clear governance disclosures.
4. IPO proceeds aimed at supporting expansion of diagnostic capacity and strengthening operations.
Modern Diagnostic & Research Centre operates as an integrated pathology and radiology diagnostic services provider with a network of centres and laboratories across India, offering comprehensive healthcare testing solutions. The company’s listing on the BSE SME platform through its IPO aims to support its ongoing expansion strategy. MDRC is positioned to benefit from increasing demand for diagnostic services in the Indian healthcare market and its broad service portfolio, which caters to individual, institutional, and corporate clients.
- कंपन्या
- प्रकार
- ओपनिंग तारीख
- श्री प्रियांका जिओ कॉमेक्स
- एसएमई
-
24 जून
- प्री-बुक
-
धनवेल हायब्रिड सीड्स
- एसएमई
-
24 जून
- प्री-बुक
-
सीएसएम टेक्नॉलॉजी
- मेनबोर्ड
-
24 जून
- प्री-बुक
एफएक्यू
Modern Diagnostic & Research Centre IPO opens from December 31, 2025 to January 2, 2026.
The size of Modern Diagnostic & Research Centre IPO is ₹37 Cr.
The price band of Modern Diagnostic & Research Centre IPO is fixed at ₹85 to ₹90 per share.
To apply for Modern Diagnostic & Research Centre IPO, follow the steps given below:
● तुमच्या 5paisa डिमॅट अकाउंटमध्ये लॉग-इन करा आणि वर्तमान IPO सेक्शनमध्ये समस्या निवडा
● Enter the number of lots and the price at which you wish to apply for the Modern Diagnostic & Research Centre IPO.
● तुमचा UPI ID प्रविष्ट करा आणि सबमिट करा वर क्लिक करा. यासह, तुमची बिड एक्सचेंजसह दिली जाईल.
तुम्हाला तुमच्या UPI ॲपमध्ये फंड ब्लॉक करण्यासाठी मँडेट नोटिफिकेशन प्राप्त होईल.
The minimum lot size of Modern Diagnostic & Research Centre IPO is of 3,200 shares and the investment required is ₹2,88,000.
The share allotment date of Modern Diagnostic & Research Centre IPO is January 5, 2026
The Modern Diagnostic & Research Centre IPO will likely be listed on January 7, 2026.
Beeline Capital Advisors Private Limited is the book running lead manager for Modern Diagnostic & Research Centre IPO.
Modern Diagnostic & Research Centre IPO plans to utilise the raised capital from the IPO for:
1. Funding capital expenditure for purchase of medical equipments for diagnostic centre and laboratories (₹20.69 कोटी)
2. Funding working capital requirement (₹8 Cr)
3. Repayment of certain outstanding borrowings availed by the company (₹1 Cr)
4. सामान्य कॉर्पोरेट खर्च